A Phase 3 interventional study of Pectin in Hypomotility and Constipation, sponsored by Nanjing PLA General Hospital. Completed. Open to participants aged 18 Years to 78 Years. Per ClinicalTrials.gov, last updated 2018-08-24.
Sponsored by Nanjing PLA General Hospital · Phase 3, Interventional, and Treatment
The purpose of this study is to investigate the effect of pectin, a kind of soluble dietary fiber, on colonic transit time, clinical symptoms and the gut microbiota in adults with slow-transit constipation.
Patients were randomized to receive either pectin or placebo. Treatment consisted of 4 weeks supplementation with pectin (fiber group) or placebo. We evaluated the colonic transit time, constipation symptoms and fecal bacterial population in two groups.
1,018 studies on the registry are indexed under Constipation; 139 are open to participants now.
This study's enrollment of 80 is close to the median of 80 across 850 interventional studies indexed under Constipation.
Browse Constipation studies →Nanjing PLA General Hospital is the lead sponsor of 17 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
pectin, a kind of soluble dietary fiber
Drug: Pectin
Placebo
pectin （Andeli Ltd. Yantai, China）, 24g/d for 4weeks
Also known as: soluble dietary fiber
efficacy: intestinal transit time
colonic transit time
Time frame: four weeks after inclusion
efficacy: clinical symptoms
Wexner constipation score
Time frame: four weeks after inclusion
efficacy: gut microbiota
real-time PCR
Time frame: four weeks after inclusion
No study locations are listed for this record.
This study is completed, as verified in Jul 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Nanjing PLA General Hospital